MGDRx EyeBag®

From £20.00

The original, effective and reusable warm compress. Heat in microwave. Reuse up to 200 times. All natural materials. Made in the UK. Release your natural oils to maintain tearfilm and ocular comfort.

EyeBag® Instant

From £10.00

For when you don't have access to a microwave. Single use disposable warm compress. Air activated. Your ideal travelling companion.

EyeBag® Omega

From £20.00

Specially formulated nutritional supplement to reduce inflammation and improve function of the ocular surface and tear film.

The MGDRx EyeBag®

£20.00
The MGDRx EyeBag®

The MGDRx EyeBag®

£20.00

has been successfully added to your cart . Feel free to continue shopping or check out .

Short description

The MGDRx EyeBag® is a patented, CE marked Class 1 medical device registered with the Medicines and Healthcare products Regulatory Agency (MHRA).

The EyeBag® is a silk and cotton device which can be re-heated up to 200 times in a microwave. Simply heat for 30 or 40 seconds on full power and the EyeBag® will stay warm for up to 10 minutes.

Our customers in Australia please visit eyebag.com.au

MGDRx EyeBag®

For the treatment of Meibomian Gland Dysfunction and relief of the following:

• Meibomian Gland Dysfunction (MGD)
• Blepharitis
• Dry Eye Syndrome
• Styes
• Eyelid Cysts (Meibomian cysts know as chalazion, pronounced Ka-lazy-on)
• Contact Lens Dry Eye
• Corneal Laser Dry Eye
• Seborrhoeic dermatitis
• Rosacea

Symptoms Relieved

Symptoms which are relieved by EyeBag® treatment are:

• Grittiness
• Tiredness
• Redness
• Bleary Vision
• Burning Discomfort
• Foreign body sensation (feels like there's something in the eye)
• Dry eye
• Eye irritation

Each EyeBag® will cost you exactly £20 with free postage and no delivery charge. EyeBags® will be sent by Royal Mail 1st Class Post and they fit through a standard letter box. Your EyeBag® will usually be dispatched within 24 hours.

Please note that free delivery applies to international orders too.

Download Instructions For Use

Dry Eye, Blepharitis and Meibomian Gland Dysfunction

Dry Eye Syndrome is the most common ophthalmic condition world wide. In the UK there are over 6 million prescriptions for dry eye drops and medications each year.

Over 90% of dry eye is evaporative and caused by Meibomian Gland Dysfunction (MGD). The normal oily secretion from these glands (meibum) is required to stabilise the lipid layer of the tear film and prevent evaporation of the aqueous portion. Effective warming of the glands releases the natural oils to restore tear film function, without introducing any foreign substance onto the ocular surface.

 

Image 1: Thick secretions blocking the Meibomian glands with debris around the lashes.

 

Effective eyelid warming is recommended in NICE Clinical Knowledge summaries for`:

Blepharitis:

https://cks.nice.org.uk/blepharitis - !scenario

Dry eye syndrome:

https://cks.nice.org.uk/dry-eye-syndrome - !scenario

Meibomian cyst (chalazion):

https://cks.nice.org.uk/meibomian-cyst-chalazion - !scenariorecommendation

Stye (hordeola):

https://cks.nice.org.uk/styes-hordeola - !scenario

The MGDRx EyeBag®, a reusable warm compress, which heats quickly and conveniently in a microwave, is a registered Class 1 Medical Device.

With high patient compliance, it is more hygienic ref 1 and effective ref 2, ref 3  than a hot wet flannel.

It is available on prescription and provides cost effective management for dry eye and blepharitis.

PLEASE SEE PRICE COMPARISON TABLE 

For electronic prescribing search MGDRX EyeBag® on systM1.

One EyeBag® lasts for 6 months reducing number of prescriptions and visits.

Effective warming resolved 46% of Chalazia in a randomised controlled trial. ref Goawalla and Lee. Clinical and experimental Ophthalmology 2007; 35:706-712

Peer reviewed research shows the EyeBag® to be both safe and effective ref 4

The Tear Film and Ocular Surface Society Published the second Dry Eye Workshop Report in July 2017. Known as TFOS DEWS2 it is a comprehensive evidence based peer reviewed assessment of the current understanding of Dry Eye in 2017. It is clear that most patients with ‘dry eye’ symptoms have Meibomian Gland Dysfunction or MGD and first line treatment for MGD is an effective warm compress.

The MGDRx EyeBag® has been shown to be more effective than a hot wet face cloth and further fully referenced information about the MGDRx EyeBag® can be found in section 3.2.2.2 of the DEWS2 report published in 'The Ocular Surface' on July 20th, 2017. You can obtain free access to the entire DEWS2 report through the TFOS website at http://www.tearfilm.org/

The EyeBag® Company will send details of all peer reviewed published EyeBag® references upon request through the ‘Contact Us’ link on this website.